Presents
How to think about NFTs
with
Richard Seet
Co-Founder Tesseract Group, Inc.
A former academic turned private equity investor turned entrepreneur turned private investor explores NFTs.
What is an NFT? Join us as we discuss non-fungible tokens, specifically NFTs in the art world with one of the experts that is about to take Tesseract public.
***
Mr. Seet has been the Chief Executive Officer and a director since Tesseract’s inception in November of 2021. Mr. Seet is also Chairman of RXS Enterprises, LLC, a private investment vehicle. Mr. Seet has been a director, trustee, and/or advisor to numerous private and public companies, including CellPoint Digital, the TED Residency, and CreateTOTALLY. In October 2020, RXS Enterprises led a $687 million take-private bid with Brookfield Special Investments for Iconix Brand Group, a leading brand management company.
Prior to RXS Enterprises, Mr. Seet was Chairman and CEO of Amity Entertainment, an independent film and children’s entertainment company he built in partnership with Angelo, Gordon & Co, a $43 billion alternative investment fund. In 2007, he won an Emmy award as an Executive Producer of The Big Comfy Couch, a children’s property owned by Amity.
Prior to Amity, Mr. Seet co-founded
Qiosk.com, a startup venture with equity financing led by United Business Media, a FTSE 100 company, providing digital distribution of multimedia interactive magazines. Qiosk’s clients include Hearst, Cahners Business Information, Crain Communications, American Lawyer Media, ABP International, Penn Well and CMP Media LLC.
Prior to Qiosk, he was a principal with the Carlyle Group (“Carlyle”) where he initiated and led Carlyle’s entry into Asia and the creation of its first Asian focused private equity funds.
Prior to Carlyle, Mr. Seet was a research associate at the Harvard Business School where he developed and authored numerous teaching case studies on Asian competitive strategy.
Mr. Seet received his S.B. at the Massachusetts Institute of Technology and his doctoral education in molecular genetics at Harvard where he was a Baxter Fellow.